SCHEMBL31757965

SCHEMBL31757965

O=C(O)Cc1ccccc1OCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFD P00746 6/20 0.68
▸ F11 P03951 5/20 0.68
▸ TPSB2 P20231 4/20 0.68
▸ KLKB1 P03952 2/20 0.68
▸ PLG P00747 1/20 0.68
▸ PLAU P00749 1/20 0.68
▸ F7 P08709 1/20 0.68
▸ PTGER1 P34995 3/20 0.65
▸ PTGER4 P35408 3/20 0.65
▸ PTGER3 P43115 3/20 0.65
▸ PTGER2 P43116 3/20 0.65
▸ HTR1A P08908 1/20 0.61
▸ DRD2 P14416 1/20 0.61
▸ L3MBTL1 Q9Y468 3/20 0.54
▸ CXCL8 P10145 2/20 0.54
▸ FABP4 P15090 1/20 0.54
▸ FABP5 Q01469 1/20 0.54
▸ FOLH1 Q04609 1/20 0.54
▸ GAA P10253 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1007508 1.00 CFD (0.68) CFDF11TPSB2KLKB1PLG
SCHEMBL5092502 0.90 CFD (0.58) CFDF11TPSB2KLKB1PLG
SCHEMBL28900188 0.89 PTGER1 (0.68) CFDF11TPSB2KLKB1PLG
SCHEMBL1412911 0.88 HTR1A (0.59) CFDF11TPSB2KLKB1PLG
SCHEMBL10591847 0.87 FABP4 (0.72) CFDF11TPSB2KLKB1PLG
SCHEMBL68571 0.86 L3MBTL1 (0.69) CFDF11TPSB2KLKB1PLG
Methane SCHEMBL22289610 0.86 HTR1A (0.57) CFDF11TPSB2KLKB1PLG
SCHEMBL1462035 0.86 HTR1A (0.57) CFDF11TPSB2KLKB1PLG
SCHEMBL31757878 0.86 HTR1A (0.57) CFDF11TPSB2KLKB1PLG
SCHEMBL17892024 0.86 ABCB1 (0.66) CFDF11TPSB2KLKB1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008758-A1 LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF INSMED INCORPORATED 2026-01-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008758-A1 LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF DPP3, DPP7, DPP9 CFD 847/4885F11 2769/4885TPSB2 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback